miR-381, a novel intrinsic WEE1 inhibitor, sensitizes renal cancer cells to 5-FU by up-regulation of Cdc2 activities in 786-O

被引:53
作者
Chen, Binghai [1 ,2 ]
Duan, Lujing [3 ]
Yin, Guangming [1 ]
Tan, Jing [1 ]
Jiang, Xianzhen [1 ]
机构
[1] Cent S Univ, Xiang Ya Hosp 3, Dept Urol, Changsha 410000, Hunan, Peoples R China
[2] Jiangsu Univ, Affiliated Hosp, Dept Urol, Zhenjiang, Peoples R China
[3] Jiangsu Univ, Affiliated Hosp, Dept Endocrinol, Zhenjiang, Peoples R China
关键词
5-FU; Cdc2; Chemotherapy; MicroRNA; miR-381; Renal cell cancer; WEE1; GENE-EXPRESSION; DOWN-REGULATION; KINASE; CHECKPOINT; CARCINOMA; MICRORNA; RADIOSENSITIZATION; IDENTIFICATION; PHOSPHATASES; PD0166285;
D O I
10.1179/1973947813Y.0000000092
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Few researches on increase of chemotherapy sensitivity by microRNA (miRNA) were reported. We aim to investigate exact role of miR-381 in chemotherapy sensitivity of 5-fluorouracil (5-FU) in renal cancer cells. Methods: We investigated the cell survival, cell-cycle and apoptosis of 786-O and HK-2 cells treated with miR-381 and 5-FU. IC50 of 5-FU was calculated. To study apoptosis and G(2)/M arrest, we determined pHH3, mitotic index and caspase-3/7 activity. Results: We showed that miR-381 combined with 5-FU inhibited proliferation and potentiated the antitumour efficacies of 5-FU at tolerated concentration in vitro. miR-381 combined with 5-FU led to Cdc2 activation, mitotic catastrophe, and cell apoptosis through inhibitory WEE1. WEE1 was also validated as the direct target of miR-381. IC50 of 5-FU decreased significantly in the presence of miR-381. Conclusion: miR-381 increases sensitivity of 786-O cells to 5-FU by inhibitory WEE1 and increase of Cdc2 activity.
引用
收藏
页码:229 / 238
页数:10
相关论文
共 39 条
[1]  
Backert S, 1999, INT J CANCER, V82, P868, DOI 10.1002/(SICI)1097-0215(19990909)82:6<868::AID-IJC16>3.0.CO
[2]  
2-W
[3]   Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis [J].
Blenk S. ;
Engelmann J.C. ;
Pinkert S. ;
Weniger M. ;
Schultz J. ;
Rosenwald A. ;
Müller-Hermelink H.K. ;
Müller T. ;
Dandekar T. .
BMC Cancer, 8 (1)
[4]   Activity of novel Cdc25 inhibitors and preliminary evaluation of their potentiation of chemotherapeutic drugs in human breast cancer cells [J].
Brault, Laurent ;
Bagrel, Denyse .
LIFE SCIENCES, 2008, 82 (5-6) :315-323
[5]   Down-Regulation of Wee1 Kinase by a Specific Subset of microRNA in Human Sporadic Pituitary Adenomas [J].
Butz, Henriett ;
Liko, Istvan ;
Czirjak, Sandor ;
Igaz, Peter ;
Khan, Mohammed Munayem ;
Zivkovic, Vladimir ;
Balint, Katalin ;
Korbonits, Marta ;
Racz, Karly ;
Patocs, Attila .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (10) :E181-E191
[6]   Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer [J].
Chen, Junqing ;
Tian, Wei ;
Cai, Hongke ;
He, Haifei ;
Deng, Yongchuan .
MEDICAL ONCOLOGY, 2012, 29 (04) :2527-2534
[7]   Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition [J].
Cozzi, Martina ;
Giorgi, Francesca ;
Marcelli, Eleonora ;
Pentimalli, Francesca ;
Forte, Iris Maria ;
Schenone, Silvia ;
D'Urso, Vittorio ;
De Falco, Giulia ;
Botta, Maurizio ;
Giordano, Antonio ;
Indovina, Paola .
CELL CYCLE, 2012, 11 (05) :1029-1039
[8]  
Gao S, 2013, CANC LETT
[9]   WEE1 Inhibition Sensitizes Basal Breast Cancer Cells to TRAIL-Induced Apoptosis [J].
Garimella, Sireesha V. ;
Rocca, Andrea ;
Lipkowitz, Stanley .
MOLECULAR CANCER RESEARCH, 2012, 10 (01) :75-85
[10]   Potential of microRNAs for cancer diagnostics, prognostication and therapy [J].
Garzon, Ramiro ;
Marcucci, Guido .
CURRENT OPINION IN ONCOLOGY, 2012, 24 (06) :655-659